0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United Kingdom Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • PDF Icon

    Report

  • 66 Pages
  • March 2025
  • Region: United Kingdom
  • GlobalData
  • ID: 6058735
Description Jump to:
The “United Kingdom Neuromodulation Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Peripheral Nerve Stimulators (PNS) and Leads

The United Kingdom Neuromodulation Devices Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Neuromodulation Devices Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Neuromodulation Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Neuromodulation Devices is segmented as follows:

  • Deep Brain Stimulators (DBS)
  • Gastric Electric Stimulators (GES)
  • Sacral Nerve Stimulators (SNS)
  • Spinal Cord Stimulators (SCS)
  • Vagus Nerve Stimulators (VNS)
  • Peripheral Nerve Stimulators (PNS)
  • Leads

Reasons to Buy

The United Kingdom Neuromodulation Devices Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, United Kingdom
3.1 Neuromodulation Devices Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.3 Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.4 Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.5 Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.6 Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2023
3.5 Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United Kingdom, Neuromodulation Devices Market
4.1 LivaNova Plc
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Nevro Corp
4.5.1 Company Overview
5 Neuromodulation Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 LivaNova Raises USD345 Million in Private Placement of 2.50% Convertible Senior Notes Due 2029
6.2 Venture Financing
6.2.1 Amber Therapeutics Secures USD100 Million in Series A Venture Financing
6.2.2 Neurovalens Raises USD2.65 Million in Venture Financing
6.2.3 Phagenesis Secures USD42 Million in Series D Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 08, 2024: LivaNova Appoints Susan Podlogar as a New Director
7.2 Financial Announcements
7.2.1 Oct 30, 2024: LivaNova Announces Q3 2024 Results
7.2.2 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
7.2.3 Sep 25, 2024: LivaNova to Announce Third-Quarter 2024 Results
7.2.4 Apr 05, 2024: RUA Life Sciences : Business Update
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 5: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 6: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 7: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 8: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Table 9: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033
Table 10: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033
Table 11: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033
Table 12: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033
Table 13: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033
Table 14: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033
Table 15: Neuromodulation Devices Market, United Kingdom, Average Price ($), 2018-2033
Table 16: Neuromodulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023
Table 17: Neuromodulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023
Table 18: Neuromodulation Devices Market Pipeline Products
Table 19: LivaNova Raises USD345 Million in Private Placement of 2.50% Convertible Senior Notes Due 2029
Table 20: Amber Therapeutics Secures USD100 Million in Series A Venture Financing
Table 21: Neurovalens Raises USD2.65 Million in Venture Financing
Table 22: Phagenesis Secures USD42 Million in Series D Funding
Table 23: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Deep Brain Stimulators (DBS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Gastric Electric Stimulators (GES) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 5: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 6: Spinal Cord Stimulators (SCS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 7: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 8: Neuromodulation Devices Market, United Kingdom, Volume (Units), 2018-2033
Figure 9: Deep Brain Stimulators (DBS) Market, United Kingdom, Volume (Units), 2018-2033
Figure 10: Gastric Electric Stimulators (GES) Market, United Kingdom, Volume (Units), 2018-2033
Figure 11: Peripheral Nerve Stimulators (PNS) Market, United Kingdom, Volume (Units), 2018-2033
Figure 12: Sacral Nerve Stimulators (SNS) Market, United Kingdom, Volume (Units), 2018-2033
Figure 13: Spinal Cord Stimulators (SCS) Market, United Kingdom, Volume (Units), 2018-2033
Figure 14: Vagus Nerve Stimulators (VNS) Market, United Kingdom, Volume (Units), 2018-2033
Figure 15: Neuromodulation Devices Market, United Kingdom, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Boston Scientific Corp
  • LivaNova PLC
  • Medtronic Plc
  • Nevro Corp

Related Topics

Related Reports

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 - Product Image

Neuromodulation Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036

  • Report
  • 53 Pages
  • Global
From
EUR$7,500USDGBP
Italy Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

Italy Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 55 Pages
  • Italy
From
EUR$4,995USDGBP
Internal Neuromodulation Devices Market Report 2025 - Product Image

Internal Neuromodulation Devices Market Report 2025

  • Report
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030 - Product Image

Neuromodulation Devices Market by Product, Application, End User - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Neuromodulation Devices Market by Product, by Application, by End-User, and By Region - Product Image

Neuromodulation Devices Market by Product, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
EUR$3,750USDGBP

About the Neuromodulation Device Market

Neuromodulation devices are medical devices used to treat neurological disorders and chronic pain. These devices are used in a variety of surgical procedures, such as deep brain stimulation, spinal cord stimulation, and sacral nerve stimulation. Neuromodulation devices are designed to deliver electrical stimulation to the nervous system, which can help reduce pain, improve movement, and restore normal functioning. Neuromodulation devices are used in a variety of surgical procedures, including neurosurgery, orthopedic surgery, and plastic surgery. In neurosurgery, neuromodulation devices are used to treat conditions such as Parkinson's disease, epilepsy, and chronic pain. In orthopedic surgery, neuromodulation devices are used to treat conditions such as spinal cord injuries, chronic pain, and muscle spasms. In plastic surgery, neuromodulation devices are used to treat conditions such as facial paralysis and facial nerve damage. Some of the companies in the neuromodulation device market include Medtronic, Boston Scientific, St. Jude Medical, Abbott, and Cyberonics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.
This website uses cookies to ensure you get the best experience. Learn more